Analytical Verification Performance of Afirma Genomic Sequencing Classifier in the Diagnosis of Cytologically Indeterminate Thyroid Nodules
Background: Fine needle aspiration (FNA) cytology, a diagnostic test central to thyroid nodule management, may yield indeterminate results in up to 30% of cases. The Afirma® Genomic Sequencing Classifier (GSC) was developed and clinically validated to utilize genomic material obtained during the FNA...
Main Authors: | Yangyang Hao, Yoonha Choi, Joshua E. Babiarz, Richard T. Kloos, Giulia C. Kennedy, Jing Huang, P. Sean Walsh |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-07-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fendo.2019.00438/full |
Similar Items
-
Risk of malignancy in cytologically indeterminate thyroid nodules harboring thyroid stimulating hormone receptor mutations
by: Dorota Whitmer, et al.
Published: (2022-12-01) -
Prevalence of cancer and the benign call rate of afirma gene classifier in 18F‐Fluorodeoxyglucose positron emission tomography positive cytologically indeterminate thyroid nodules
by: Mayumi Endo, et al.
Published: (2021-02-01) -
Diagnostic Performance of Afirma and Interpace Diagnostics Genetic Testing in Indeterminate Thyroid Nodules: A Single Center Study
by: Emad Kandil, et al.
Published: (2023-03-01) -
Analytical performance of Envisia: a genomic classifier for usual interstitial pneumonia
by: Yoonha Choi, et al.
Published: (2017-11-01) -
Indeterminate Thyroid Nodules: From Cytology to Molecular Testing
by: Paola Vignali, et al.
Published: (2023-09-01)